Suppr超能文献

相似文献

3
Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
PLoS One. 2015 May 5;10(5):e0124985. doi: 10.1371/journal.pone.0124985. eCollection 2015.
4
Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
Immunogenetics. 2018 Mar;70(3):169-177. doi: 10.1007/s00251-017-1026-2. Epub 2017 Aug 25.
6
Association between IFITM3 rs12252 polymorphism and influenza susceptibility and severity: A meta-analysis.
Gene. 2018 Oct 20;674:70-79. doi: 10.1016/j.gene.2018.06.070. Epub 2018 Jun 22.
7
Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population.
Front Cell Infect Microbiol. 2017 Jun 30;7:294. doi: 10.3389/fcimb.2017.00294. eCollection 2017.
8
Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
J Infect Dis. 2017 Jul 1;216(1):14-21. doi: 10.1093/infdis/jix242.
9
IFITM3 and severe influenza virus infection. No evidence of genetic association.
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1811-1817. doi: 10.1007/s10096-016-2732-7. Epub 2016 Aug 4.

引用本文的文献

1
variants point to a critical role in emergent virus infections.
mBio. 2025 May 14;16(5):e0334724. doi: 10.1128/mbio.03347-24. Epub 2025 Apr 16.
2
Pleiotropic Bias and Study Design Considerations in Genetic Association Studies.
Med J Islam Repub Iran. 2024 May 7;38:51. doi: 10.47176/mjiri.38.51. eCollection 2024.
4
Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.
Pathogens. 2024 Jan 29;13(2):127. doi: 10.3390/pathogens13020127.
6
Rapid, label-free and low-cost diagnostic kit for COVID-19 based on liquid crystals and machine learning.
Biosens Bioelectron X. 2022 Dec;12:100233. doi: 10.1016/j.biosx.2022.100233. Epub 2022 Sep 8.
7
In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate.
Virol J. 2022 May 23;19(1):88. doi: 10.1186/s12985-022-01823-0.
8
Mammalian and Avian Host Cell Influenza A Restriction Factors.
Viruses. 2021 Mar 22;13(3):522. doi: 10.3390/v13030522.
10
Antiviral Protection by IFITM3 In Vivo.
Curr Clin Microbiol Rep. 2018 Dec;5(4):229-237. doi: 10.1007/s40588-018-0103-0. Epub 2018 Aug 3.

本文引用的文献

1
Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
EMBO Rep. 2016 Nov;17(11):1657-1671. doi: 10.15252/embr.201642771. Epub 2016 Sep 6.
2
IFITM3 and severe influenza virus infection. No evidence of genetic association.
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1811-1817. doi: 10.1007/s10096-016-2732-7. Epub 2016 Aug 4.
4
Host genetics of severe influenza: from mouse Mx1 to human IRF7.
Curr Opin Immunol. 2016 Feb;38:109-20. doi: 10.1016/j.coi.2015.12.002. Epub 2016 Jan 4.
5
Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
PLoS One. 2015 May 5;10(5):e0124985. doi: 10.1371/journal.pone.0124985. eCollection 2015.
6
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):769-74. doi: 10.1073/pnas.1321748111. Epub 2013 Dec 23.
7
IFITM3 and susceptibility to respiratory viral infections in the community.
J Infect Dis. 2014 Apr 1;209(7):1028-31. doi: 10.1093/infdis/jit468. Epub 2013 Aug 30.
8
The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Cell Host Microbe. 2013 Apr 17;13(4):452-64. doi: 10.1016/j.chom.2013.03.006.
9
Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins.
Microbes Infect. 2013 Apr;15(4):280-90. doi: 10.1016/j.micinf.2012.12.003. Epub 2013 Jan 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验